Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel pyridine derivative and pyrimidine derivative (3)

A pyridine and piperidine technology, which can be used in drug combinations, cardiovascular system diseases, organic active ingredients, etc., and can solve problems such as unreported and unrecorded compounds

Inactive Publication Date: 2012-05-09
EISIA R&D MANAGEMENT CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the compounds related to the present invention are not described in Patent Documents 12 and 13, and there is no report on the HGFR inhibitory effect of the compounds disclosed in Patent Documents 12 and 13.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel pyridine derivative and pyrimidine derivative (3)
  • Novel pyridine derivative and pyrimidine derivative (3)
  • Novel pyridine derivative and pyrimidine derivative (3)

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0465] This step is a step of obtaining compound (1t) from compound (1ps) (compound (1ps) is compound (1p) and compound (1s) described in [Production method 1-B].). The same method as can be used.

[0466]

[0467] This step is a step of obtaining compound (1u) from compound (1t). The same method as can be used.

[0468]

[0469] This step is the compound (1u) 2 protecting groups " R 102 -O-C(=O)-" and "P" are deprotected to obtain the compound (1x). According to the type of protecting group, the following reactions can be appropriately combined to carry out this step, thereby obtaining the compound (1x), namely Deprotection reactions using acids such as hydrochloric acid and trifluoroacetic acid; deprotection reactions using inorganic bases such as sodium hydroxide and potassium hydroxide; deprotection reactions using tetrabutylammonium fluoride, etc.; by using palladium carbon, palladium hydroxide Such as the deprotection reaction carried out by the catalytic hydrog...

Embodiment

[0646] The compounds of the present invention can be produced, for example, according to the methods described in the following Preparations and Examples. However, these are illustrative examples, and the compounds of the present invention are not limited to the following specific examples in any way.

[0647] Unless otherwise specified, YMCSIL-60-400 / 230W was used as silica gel for purification in the preparation examples and examples.

[0648] In addition, unless otherwise specified, any one of the following two conditions (gradient elution condition 1 or gradient elution condition 2) was used as the LC-MS purification conditions.

[0649] ODS column (CAPCELL PAK C-18)

[0650] Solvent Liquid A Water

[0651] Solvent Liquid B Acetonitrile

[0652] Solvent C liquid 1% trifluoroacetic acid aqueous solution

[0653] Flow rate 30ml / min

[0654] End time 10min

[0655] Gradient elution condition 1

[0656] 0.00min A: 80%, B: 10%, C: 10%

[0657] 7.80min A: 30%, B: 60%, C:...

preparation example 1

[0664] (Preparation Example 1) tert-butyl 3-dimethylaminoazetidine-1-carboxylate

[0665] To a solution of 1-Boc-azetidin-3-one (3.45 g) in methanol (175 ml) was added 2M dimethylamine-tetrahydrofuran solution (21.9 ml), acetic acid (1.73 ml), 10% palladium on carbon ( 2.15 g), stirred at room temperature in a hydrogen atmosphere for 14 hours. The catalyst was filtered off, and the filtrate was concentrated under reduced pressure. The residue was partitioned between ethyl acetate-saturated aqueous sodium bicarbonate. The combined organic layers were dried over anhydrous sodium sulfate. It was concentrated to obtain the title compound (4.07 g, 101%) as a colorless oil.

[0666] 1 H-NMR spectrum (CDCl 3 )δ (ppm): 1.43 (9H, m), 2.17 (6H, s), 3.01 (1H, m), 3.79 (2H, m), 3.91 (2H, m).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
absorbanceaaaaaaaaaa
absorbanceaaaaaaaaaa
Login to View More

Abstract

A compound represented by the general formula: (I) (wherein R1 means a 3- to 10-membered nonaromatic heterocyclic group or the like; R2 and R3 mean a hydrogen atom; R4, R5, R6 and R7 are the same or different and mean a hydrogen atom, a halogen atom, a C1-6 alkyl group or the like; R8 means a hydrogen atom or the like; R9 means a 3- to 10-membered nonaromatic heterocyclic group or the like; n means an integer of 1 to 2; and X means a group represented by the formula -CH= or a nitrogen atom), a salt thereof or a hydrate thereof has an excellent hepatocyte growth factor receptor (HGFR) inhibitory action, and exhibits an anti-tumor action, angiogenesis inhibitory action or cancer metastasis inhibitory action.

Description

technical field [0001] The present invention relates to novel pyridine derivatives and pyrimidine derivatives or their salts or their hydrates, which have hepatocyte growth factor receptor inhibitory effects, antitumor effects, angiogenesis inhibitory effects, and cancer metastasis inhibitory effects. Background technique [0002] It has been reported that hepatocyte growth factor receptor (hepatocyte growth factor receptor; ”) overexpression (Non-Patent Document 1). It is generally believed that the HGFR expressed in the above-mentioned tumor cells is often stimulated by hepatocyte growth factor (hepatocyte growth factor; hereinafter referred to as "HGF") to cause autophosphorylation of tyrosine kinase in the intracellular region, so it is related to cancer malignancy. (Abnormal proliferation, invasion or metastatic hyperfunction). [0003] In addition, it has been reported that HGFR is also expressed in vascular endothelial cells, and HGF stimulates HGFR to promote the p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D213/75A61K31/4409A61K31/496A61K31/506A61K31/5377A61P35/00A61P35/04A61P43/00C07D239/47C07D401/12
CPCC07D401/14C07D401/12C07D213/75C07D239/47C07D403/12C07D405/12C07D409/14C07D413/14C07D417/14A61P35/00A61P35/04A61P43/00A61P9/00A61K31/4409
Inventor 松岛知广高桥惠子船坂势津雄尾叶石浩白鸟修司
Owner EISIA R&D MANAGEMENT CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com